PS-132-The acetyl-CoA carboxylase inhibitor PF-05221304 exerts direct effects on hepatic inflammation and fibrosis independent of benefits on steatosis.

Saved in:
Bibliographic Details
Title: PS-132-The acetyl-CoA carboxylase inhibitor PF-05221304 exerts direct effects on hepatic inflammation and fibrosis independent of benefits on steatosis.
Authors: Ross, Trenton, Kelly, Kenneth, Rinaldi, Anthony, Lech, Matthew, Martinez, Robert, Crowley, Collin, Gonzalez, Santos Carvajal, Boucher, Magalie, Shanthappa, Dinesh Hirenallur, Morin, Jeffrey, Opsahl, Alan C., RVargas, Sarah, Bence, Kendra, Pfefferkorn, Jeffrey A, Esler, William
Source: Journal of Hepatology. Apr2019 Supplement, Vol. 70, pe86-e86. 1p.
Database: Academic Search Ultimate
Description
ISSN:01688278
DOI:10.1016/S0618-8278(19)30150-1